rp12146,vusolimogene,tenalisib
replimune,rhizen,incozen therapeutics
['breast', 'solid tumor', 'rp12146', 'tenalisib', 'rp1', 'rhizen']
rhizen pharmaceuticals ag announces upcoming data presentations at esmo 2022 for its clinical stage assets; tenalisib in locally advanced/ metastatic breast cancer and rp12146 in multiple solid tumors 
Up-to-date news about Syria